Exploratory trial to examine the safety and effectiveness of transdermal electrical stimulation for retinitis pigmentosa
- Conditions
- retinitis pigmentosa
- Registration Number
- JPRN-UMIN000028190
- Lead Sponsor
- Chiba university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Not provided
cases who conflict with any of the following must not include this study. (1) Patients complicated of macular lesions such as vitreous macular traction syndrome, macular edema, epiretinal membrane, and myopia with posterior staphyloma associated with myopia (2) Patients undergoing internal eye surgery within 3 months (3) Patients who changed the dose and usage of isopropyl unoprostone, calcium antagonist, dark adaptation improving drug within 31 days before screening (4) Patients who have a history of drug allergy to drugs to be used during the trial period (mydriatic drugs, eye drops anesthetics, etc.) (5) Patients complicated with diabetic retinopathy (6) Patients who are currently complaining of external eye inflammation, infection, or severe dry eye (7) Patients who may be pregnant or pregnant. Patient who is breastfeeding. Patients who want pregnancy during the trial period (8) Patients with a history of optic nerve disease (9) Evaluation of efficacy nuclear cataract with moderate degree (grade 3 in Emery classification) to the eyes, patients with complication of anterior subcapsular, subcapsular cataract, or late cataract which have a serious effect on vision (10) Patients whose Mean Deviation (MD) value of HFA 10-2 has deteriorated by 3 dB or more per year (11) Patients who have not seen any deterioration in visual acuity, OCT findings, dynamic visual field inspection (Gp) findings, and visual field sensitivities at HFA 10-2 in the last 3 years (12) Patients currently participating in other clinical trials (13) patients under investigational responsibility (shared) doctors judged inappropriate for participation in this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method